ProKidney Corp. (PROK)
ProKidney Statistics
Share Statistics
ProKidney has 292.7M shares outstanding. The number of shares has increased by 2.55% in one year.
| Shares Outstanding | 292.7M |
| Shares Change (YoY) | 2.55% |
| Shares Change (QoQ) | 0.34% |
| Owned by Institutions (%) | 40.35% |
| Shares Floating | 208.87M |
| Failed to Deliver (FTD) Shares | 1.07K |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 11.93M, so 9.21% of the outstanding shares have been sold short.
| Short Interest | 11.93M |
| Short % of Shares Out | 9.21% |
| Short % of Float | 13.12% |
| Short Ratio (days to cover) | 34.63 |
Valuation Ratios
The PE ratio is -3.48 and the forward PE ratio is -1.22. ProKidney's PEG ratio is 0.22.
| PE Ratio | -3.48 |
| Forward PE | -1.22 |
| PS Ratio | 2805.7 |
| Forward PS | 3.9 |
| PB Ratio | -0.21 |
| P/FCF Ratio | -1.69 |
| PEG Ratio | 0.22 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for ProKidney.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.93, with a Debt / Equity ratio of 0.
| Current Ratio | 10.93 |
| Quick Ratio | 10.93 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | -20408.44 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $372.55 |
| Profits Per Employee | $-299.93K |
| Employee Count | 204 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -598K |
| Effective Tax Rate | 0.58% |
Stock Price Statistics
The stock price has increased by -70.36% in the last 52 weeks. The beta is 1.59, so ProKidney's price volatility has been higher than the market average.
| Beta | 1.59 |
| 52-Week Price Change | -70.36% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.74 |
| Relative Strength Index (RSI) | 43.13 |
| Average Volume (20 Days) | 681.44K |
Income Statement
In the last 12 months, ProKidney had revenue of 76K and earned -61.19M in profits. Earnings per share was -0.48.
| Revenue | 76K |
| Gross Profit | 76K |
| Operating Income | -183.68M |
| Net Income | -61.19M |
| EBITDA | -158.49M |
| EBIT | -163.92M |
| Earnings Per Share (EPS) | -0.48 |
Balance Sheet
The company has 99.12M in cash and 2.47M in debt, giving a net cash position of 96.65M.
| Cash & Cash Equivalents | 99.12M |
| Total Debt | 2.47M |
| Net Cash | 96.65M |
| Retained Earnings | -1.2B |
| Total Assets | 441.07M |
| Working Capital | 359.67M |
Cash Flow
In the last 12 months, operating cash flow was -126.35M and capital expenditures 0, giving a free cash flow of -126.35M.
| Operating Cash Flow | -126.35M |
| Capital Expenditures | 0 |
| Free Cash Flow | -126.35M |
| FCF Per Share | -1 |
Margins
Gross margin is 100%, with operating and profit margins of -241678.95% and -80507.89%.
| Gross Margin | 100% |
| Operating Margin | -241678.95% |
| Pretax Margin | -135193.42% |
| Profit Margin | -80507.89% |
| EBITDA Margin | -208542.11% |
| EBIT Margin | -241678.95% |
| FCF Margin | -166251.32% |
Dividends & Yields
PROK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PROK is $6, which is 700% higher than the current price. The consensus rating is "Hold".
| Price Target | $6 |
| Price Target Difference | 700% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -0.54 |
| Piotroski F-Score | 1 |